Director Deals - (APF)

Julian Treger, Chief Executive Officer, sold 115,000 shares in the company on the 16th December 2021 at a price of £1.28. The Director now holds...

Tue, 21/12/2021 - 06:00


Director Deals - (APF)

Julian Treger, Chief Executive Officer, sold 350,000 shares in the company on the 17th December 2021 at a price of £1.29. The Director now holds...

Tue, 21/12/2021 - 06:00


Director Deals - (APF)

Nicolas Meier, Non Executive Director, bought 100,775 shares in the company on the 17th December 2021 at a price of £1.29. The Director now holds...

Tue, 21/12/2021 - 06:00


FTSE 100 recovers some poise but still down 1% amid Omicron fears

The FTSE 100 recovered some ground by midday to trade 1.1% higher at 7,192.80 after falling by more than 2% early on as the rapid...

Mon, 20/12/2021 - 11:58


Savannah Energy expects to publish admission document this week

Mining group Savannah Energy said it expected to publish an admission document for the restoration of trading of its shares on AIM on around Wednesday....

Mon, 20/12/2021 - 10:05


InnovaDerma narrows annual losses as margins improve

UK beauty brand developer InnovaDerma reported narrower annual losses as margin improvements offset a fall in revenue.

For the 12 months ended 30 June...

Mon, 20/12/2021 - 09:58


Gore Street NAV rises in H1 as portfolio expands

Gore Street reported a rise in net assets under management in the first half of the year following an expansion in the value of its...

Mon, 20/12/2021 - 09:53


Providence Resources delays completion of Barryroe field review

Oil company Providence Resources said it had delayed the completion of a strategic review of its Barryroe asset offshore Ireland until early next year.

The...

Mon, 20/12/2021 - 09:47


Oriole Resources reports positive drilling results from Cameroon gold project

Mining company Oriole Resources said it had intersected good widths and grades at its 90%-owned Bibemi gold project in Cameroon.

Drilling had delivered best mineralised...

Mon, 20/12/2021 - 09:35


Hemogenyx Pharmaceuticals signs partnership with WuXi Advanced Therapies

Hemogenyx Pharmaceuticals said it had partnered with WuXi Advanced Therapies to accelerate its HEMO-CAR-T programme for acute myeloid leukaemia toward phase I clinical trials....

Mon, 20/12/2021 - 09:34


Pages